* Core Laboratories NV CLB.N CLB is expected to show a rise
in quarterly revenue when it reports results on July 28.
* The Amsterdam, Noord-holland-based company is expected to
report a 3.1% increase in revenue to $119.28 million from
$115.74 million a year ago, according to the mean estimate from
6 analysts, based on Refinitiv data.
* Refinitiv's mean analyst estimate for Core Laboratories NV is
for earnings of 19 cents per share. For the same quarter last
year, the company reported earnings of 14 cents per share.
* The current average analyst rating on the shares is "hold" and
the breakdown of recommendations is 3 "strong buy" or "buy," 8
"hold" and 1 "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in the
last three months.
* Wall Street's median 12-month price target for Core
Laboratories NV is $33, about 3.3% below its last closing
price of $34.08.
* Previous quarterly performance (using preferred earnings
measure in US dollars).
QUARTER STARMINE REFINITIV ACTUAL BEAT, SURPRI
ENDING SMARTESTIM IBES MET, SE %
ATE® ESTIMATE MISSED
Mar. 31 2021 0.12 0.13 0.15 Beat 15
Dec. 31 2020 0.15 0.15 0.18 Beat 16.5
Sep. 30 2020 0.13 0.15 0.16 Beat 9.2
Jun. 30 2020 0.10 0.10 0.14 Beat 42.1
Mar. 0.31 0.34 0.31 Missed -7.5
31 2020
Dec. 31 2019 0.37 0.37 0.38 Beat 2.2
Sep. 30 2019 0.49 0.49 0.50 Beat 2.8
Jun. 30 2019 0.46 0.46 0.46 Met 0.5
This summary was machine generated July 27 at 01:42 GMT. All
figures in US dollars unless otherwise stated